**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 10127-02-3 |ACRIDINE ORANGE | 55 | 233-353-6 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Limited evidence of a carcinogenic effect.Hygroscopic (absorbs
moisture from the air).The toxicological properties of this material
have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. Can produce delayed
pulmonary edema.
Chronic:
Prolonged or repeated skin contact may cause dermatitis. Effects may
be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
Antidote:
The use of Calcium disodium EDTA as a chelating agent should be
determined by qualified medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Minimize dust generation and
accumulation. Avoid contact with eyes, skin, and clothing. Keep
container tightly closed. Avoid ingestion and inhalation. Use with
adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 10127-02-3:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: orange
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not applicable.
Boiling Point: Not applicable.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Soluble in water.
Specific Gravity/Density: Not available.
Molecular Formula: C17H20N3Cl.5ZnCl2
Molecular Weight: 369.94
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, ignition sources, dust generation, excess
heat, strong oxidants, exposure to moist air or water.
Incompatibilities with Other Materials:
Moisture.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, irritating and
toxic fumes and gases, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 10127-02-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
ACRIDINE ORANGE -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 10127-02-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 10127-02-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 10127-02-3 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 4/05/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Cumene-d12, 99 atom % D
| 0-00-1 |
|
Methyl Methacrylate-D8, 99.5 Atom % D, Stabilized with 100 ppm
| 0-00-1 |
|
Methylcyclohexane-d14, 99.5 atom % D
| 108-87-2 |
|
Ethylene Glycol-D6, 99 Atom % D
| 15054-86-1 |
|
Ethyl alcohol-d6, anhydrous, 99 Atom % D
| 64-17-5 |
|
Methyl-d3 alcohol, 99.5 atom % D
| 67-56-1 |
|
(S,S)-(+)-2,2-Dimethyl-5-Methylamino-4-Phenyl-1,3-Dioxane
| 0-00-1 |
|
2,2-Dimethyl-1,3-Dioxan-5-One
| 74181-34-3 |
|
1,2,2,6,6-Pentamethyl-4-Piperidinol
| 2403-89-6 |
|
2,2'-Dithio(bis)benzothiazole
| 120-78-5 |
|
Acridine Orange, ca. 55%
| 10127-02-3 |
|
Cyclopentadienylmolybdenum Tricarbonyl Sodium
| 12107-35-6 |
|
Tetrabenzylzirconium
| 24356-01-2 |
|
2-Methylcyclohexanol, P.A.; Mixture of Cis and Trans
| 583-59-5 |
|
1,2-Bis(dicyclohexylphosphino)ethane nickel(II) chloride
| 96555-88-3 |
|
1-Octene, 99+%
| 111-66-0 |
|
Lauric Acid, 99.8+% (GC)
| 143-07-7 |
|
Ethylenediaminetetraacetic Acid, Tripotassium Salt Dihydrate (Pract),
| 7732-18-5 |
|
alpha-Terpineol, 99%
| 98-55-5 |
|
Calcium bromide hydrate
| 7789-41-5 |
|
3-Hydroxy-N-Methylpiperidine, 97%
| 3554-74-3 |
|
2-Hydroxymethyl-12-Crown-4, Tech., 93% (gGC)
| 75507-26-5 |
|
Methyl(2E,4S)-(-)-4-(phenylmethoxy)pent-2-enoate
| 112489-57-3 |
|
Ethyl Isocyanoacetate, 97% (GC)
| 2999-46-4 |
|
N-Iodosuccinimide
| 516-12-1 |
|
3,5-Dichlorobenzotrifluoride
| 0-00-1 |
|
DL-Methionine, Feed Grade
| 59-51-8 |
|
2-Vinyl-1,3-dioxolane
| 3984-22-3 |
|
N-Glycine, E.P. Pyrogene Free
| 56-40-6 |
|
D(-)-glutamine
| 5959-95-5 |
|
4,5-Dihydroxynaphthalene-2,7-Disulfonic Acid, Disodium Salt
| 5808-22-0 |
|
Albumine Bovine, Fraction V (pH:7.0)
| 94349-60-7 |
|
n-Methyl-2,2,6,6-tetramethyl-4-piperidinol 99%
| 50-01-4 |
|
Ethyl cis-2-amino-1-cyclopentane carboxylate hydrochloride, 99%
| 142547-15-7 |
|
cis-2-(Benzyloxycarbonylamino)-1- cyclopentanecarboxylic acid
| |
|
3',4'-(Didodecyloxy)benzaldehyde, 99% (GC)
| 117241-25-5 |
|
2-Amino-1,2,3,4-Tetrahydronaphthalene-2- Carboxylic Acid
| 0-00-0 |
|
2,2',4'-Trichloroacetophenone, 99% (gc)
| 4252-78-2 |
|
3-Aminophenol, 99%
| 591-27-5 |
|
Alpha-Naphtholbenzein
| 6948-88-5 |
|
cis-2-Aminomethylcycloheptanol hydrochloride
| 0-00-0 |
|
n-(Tributyl)tinpyrrole
| 50486-65-2 |
|
2-Benzoyl-1-cyano-6,7-dimethoxy-1,2,3,4- tetrahydroisoquinoline
| |
|
Aluminum, Powder, -120 Mesh, 99,99%
| 7429-90-5 |
|
3-Amino-4-methylpentanoic acid
| 2458-12-0 |
|
3-Hydroxy-2,2-dimethyl-3-phenylpropionic- acid
| 0-00-0 |
|
(4S,2RS)-2,5,5-Trimethylthiazolidine-4- Carboxylic Acid
| 0-00-0 |
|
Bromobenzene-d5
| 108-86-1 |
|
3-Amino-1-phenoxy-2-propanol hydrochloride, 98%
| 4287-20-1 |
|
Tetrathiafulvalene, 99+%
| 31366-25-3 |
|
|